Pharma Journalist -

SMi Reports: Registration is open for SMi Group’s 2nd annual Wearable Injectors and Connected Devices Conference taking place 18th -19th October in London. This Conference will explore…
Read More...

PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer…
Read More...

Charles River Laboratories International, Inc. announced that it has signed a definitive agreement to acquire Vigene Biosciences, Inc., a premier, U.S.-based gene therapy contract…
Read More...

AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced that the US Food and Drug…
Read More...

Lennham Pharmaceuticals, a clinical-stage start-up focused on the creative use of deuterium chemistry to improve the metabolic and pharmacological profile of existing compounds,…
Read More...

In Q4 2020 CordenPharma announced both an expansion of non-GMP capacity at our Centre of Excellence for Peptide Process Development in Frankfurt, Germany, and a major increase in…
Read More...

Dr. Reddy's Laboratories Ltd. and Shenzhen Pregene Biopharma Co., Ltd. announced an agreement whereby Dr Reddy's will acquire an exclusive license in the Republic of India for PRG1801,…
Read More...

Eli Lilly and Company and MiNA Therapeutics Limited, a pioneer in RNA activation therapeutics, announced a global research collaboration to develop novel drug candidates using MiNA's…
Read More...

Novasep, a leading supplier of services and technologies for the life sciences industry, is pleased to announce today a further expansion of its Highly Potent Active Pharmaceutical…
Read More...

PerkinElmer, Inc. is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second…
Read More...